As low- and middle-income countries set their sights on the global elimination of hepatitis C virus (HCV) by 2030, adoption of WHO recommendations for diagnosis and improved access to testing will be critical. We believe that better market intelligence will lower supply- and demand-side barriers and help to eliminate HCV for good. This is why FIND and CHAI have collaborated, with support from Unitaid, to release a market intelligence analysis of HCV diagnostic products covering 29 low- and middle-income countries, which account for approximately 80% of absolute HCV viraemic burden in LMICs. The report provides 5-year forecasts on need and demand for screening, confirmatory and monitoring tests and outlines the elements driving the projections and what factors will allow countries to diagnose more patients.
Download the report here.